# Hinge Health, Inc.: filings

HNGE · NYSE · CIK 1673743 · [Technology](/sectors/technology.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/hnge.md) · [Financials](/companies/hnge/financials.md) · [Filings](/companies/hnge/filings.md) · [Insiders](/companies/hnge/insiders.md)

## Reports and events: 24 filings

Newest first, by EDGAR acceptance time (Eastern). Filter with ?form= one of: `periodic`, `8-K`, `10-K`, `10-Q`, `4`, `proxy`, `13dg`, `all`, or any form this company filed (4 112, 144 80, SCHEDULE 13G/A 14, 8-K 13, SCHEDULE 13G 13, 3 12, D 9, CORRESP 6, UPLOAD 6, 10-Q 4, S-1/A 4, DRS/A 2, DRSLTR 2, S-8 2, 10-K 1, 144/A 1, 424B4 1, 8-A12B 1, ARS 1, CERT 1, D/A 1, DEF 14A 1, DEFA14A 1, DRS 1, EFFECT 1, S-1 1).

| Filed | Accepted | Form | What it is | Accession |
| --- | --- | --- | --- | --- |
| 2026-11-02 | 16:06 ET | [8-K](/filings/0001628280-26-068872.md) | 2.02 Results of operations; 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001628280-26-068872 |
| 2026-08-21 | 16:26 ET | [8-K](/filings/0001628280-26-058439.md) | 1.01 Entry into a material agreement; 2.03 New direct financial obligation | 0001628280-26-058439 |
| 2026-08-06 | 16:14 ET | [10-Q](/filings/0001628280-26-054327.md) | Quarterly report, period 2026-06-30 | 0001628280-26-054327 |
| 2026-08-04 | 16:08 ET | [8-K](/filings/0001628280-26-052558.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001628280-26-052558 |
| 2026-06-09 | 16:06 ET | [8-K](/filings/0001628280-26-041886.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001628280-26-041886 |
| 2026-06-04 | 16:19 ET | [8-K](/filings/0001628280-26-040802.md) | 5.07 Shareholder vote results | 0001628280-26-040802 |
| 2026-05-07 | 16:33 ET | [10-Q](/filings/0001628280-26-032224.md) | Quarterly report, period 2026-03-31 | 0001628280-26-032224 |
| 2026-05-05 | 16:06 ET | [8-K](/filings/0001628280-26-030499.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001628280-26-030499 |
| 2026-04-17 | 08:04 ET | [DEF 14A](/filings/0001628280-26-025602.md) | Proxy statement, period 2026-06-03 | 0001628280-26-025602 |
| 2026-03-17 | 16:06 ET | [8-K](/filings/0001628280-26-018710.md) | 5.02 Departure or appointment of officers or directors | 0001628280-26-018710 |
| 2026-03-03 | 16:11 ET | [10-K](/filings/0001628280-26-013808.md) | Annual report, period 2025-12-31 | 0001628280-26-013808 |
| 2026-02-10 | 16:07 ET | [8-K](/filings/0001628280-26-006826.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001628280-26-006826 |
| 2025-11-12 | 09:05 ET | [8-K](/filings/0001193125-25-276208.md) | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-25-276208 |
| 2025-11-07 | 16:10 ET | [10-Q](/filings/0001193125-25-272353.md) | Quarterly report, period 2025-09-30 | 0001193125-25-272353 |
| 2025-11-04 | 16:07 ET | [8-K](/filings/0001193125-25-264667.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-25-264667 |
| 2025-08-13 | 16:15 ET | [8-K](/filings/0000950170-25-108048.md) | 8.01 Other events | 0000950170-25-108048 |
| 2025-08-11 | 16:19 ET | [10-Q](/filings/0000950170-25-106577.md) | Quarterly report, period 2025-06-30 | 0000950170-25-106577 |
| 2025-08-05 | 16:06 ET | [8-K](/filings/0000950170-25-103024.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000950170-25-103024 |
| 2025-05-23 | 17:14 ET | [8-K](/filings/0001193125-25-125916.md) | 5.03 Amendment to articles or bylaws; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-25-125916 |
| 2025-05-16 | 17:28 ET | [S-1/A](/filings/0001193125-25-121827.md) | Registration statement, amended | 0001193125-25-121827 |
| 2025-05-13 | 06:19 ET | [S-1/A](/filings/0001193125-25-118259.md) | Registration statement, amended | 0001193125-25-118259 |
| 2025-05-05 | 17:08 ET | [S-1/A](/filings/0001193125-25-112887.md) | Registration statement, amended | 0001193125-25-112887 |
| 2025-04-07 | 17:11 ET | [S-1/A](/filings/0001193125-25-074751.md) | Registration statement, amended | 0001193125-25-074751 |
| 2025-03-10 | 16:45 ET | [S-1](/filings/0001193125-25-051004.md) | Registration statement | 0001193125-25-051004 |

Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Nov 2, 2026, 20:26 ET. No prices; not investment advice.